Cystic Fibrosis
Cystic Fibrosis Foundation Lauds Congress for Passage of Small Business Innovation Research Program
Published in Medical Verdicts and Law Weekly, May 8th, 2008
In response to testimony from Robert J. Beall, Ph.D., president and CEO of the Foundation, the legislation includes a provision requiring that special attention be given to research for rare diseases, such as cystic fibrosis, when SBIR grants are awarded.
The SBIR program provides grants to small biotechnology and pharmaceutical companies for research and development programs focused on innovative treatments for rare diseases.
"We congratulate members of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- Adverse Drug Reactions
Herbalife Responds to Spain's Ministry of Health Alert - Ascendant Solutions, Inc.
Ascendant Solutions Announces the Sale of Medicine Man Pharmacies - BioDefense Corporation
Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection - Biologics
Insmed to Present at CBI Follow-On Biologics Conference - BioMed Realty Trust, Inc.
BioMed Realty Trust Announces Exercise of Over-Allotment Option for Common Stock - bioMETRX Inc.
bioMETRX, Inc. Initiates Integration of Personnel and Assets of Sequiam Corp. - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
